Survey 26 - Montina FX in obese patientsMCI Registration NumberFULL NAME (As in your Pancard)EmailPhone/MobileCityStateSpecialityBank DetailsAccount Holder NameA/c NumberIFSC CodeUpload Cancelled Cheque (Max Size - 2 MB)Choose File Pancard NumberUpload Pancard Details (Max Size - 2 MB)Choose File HCP Questionnaire: Relevance & Effectiveness of higher dose of Fexofenadine (180) mg in Obese Patients with Allergic Conditions in Montelukast & Fexofenadine Fixed Dose Combination1. In your practice, "What percentage of your allergic rhinitis (AR) patients are obese? Less than 10% 10–25% 25–50% More than 50%2. In your experience, do obese patients tend to present with more severe allergic symptoms compared to non-obese individuals? Yes No Sometimes Not sure3. Which allergic condition do you most commonly observe among your obese patients? Seasonal Allergic rhinitis Perennial Allergic rhinitis AR with other co-morbidity (Hypertension/Diabetes)4. In your practice, do you increase the Fexofenadine dose from 120mg to 180mg in obese patients who do not respond sufficiently to Fexofenadine 120mg? Yes No Rarely5. Based on your experience, do you believe a higher dose of fexofenadine (e.g., 180 mg vs 120 mg or higher frequency) can provide better symptom control in obese allergic patients? Yes – clearly better control Sometimes – depending on severity No – response is similar Not sure6. Do you find that obese patients generally require a longer course of Fexofenadine 180mg therapy to achieve enhanced symptom relief? Yes No Not sure It varies from case to case7. For what typical duration do you prescribe fexofenadine 180mg in obese patients with allergic conditions? Less than 1 week 1–2 weeks 2–4 weeks More than 4 weeks8. How would you compare the effectiveness of fexofenadine 180 mg in obese patients versus non-obese patients? More effective Similarly effective Less effective Not sure9. Do you think obesity could impact the clinical response to antihistamines such as low dose of fexofenadine (60mg 0r 120mg)? Yes – due to altered pharmacokinetics No Not sure Possibly due to other factors10. Which of the following benefits do you associate with fexofenadine 180mg in your allergic patients? (Select all that apply) Non-sedative Rapid onset Long duration Safe in comorbid patients / Good tolerability11. What are the most common reasons you have observed for patients being dissatisfied or switching from fexofenadine 60mg or 120mg? Inadequate symptom relief Delayed onset Increased dose frequency in a day I have read and agree to the Terms and Conditions .Submit Form